Given that the ADF regimen improved specific metabolic parameters but induced hypercholesterolemia in Apoe−/− mice as we previously described, it must be cautious when ADF intervention is applied to the population carrying ApoE-ε4 because of its potentially harmful effects on atherosclerosis. The gene discussed is APOE; the disease is familial hypercholesterolemia.